-
Over 6 million tons! The oil and gas equivalent of the North China oilfield hit a 30-year high
Time of Update: 2023-02-02
In terms of oilfield development, North China Oilfield insists on attaching equal importance to scale and efficiency, makes overall plans to grasp the upper production of Bayan New Area and the stable production of the old area of Erlian in central Hebei, and completes the goals and tasks of the company's exploration and production acceleration development plan from 2019 to 2025 three years ahead of schedule, and crude oil production has reached a new high in 20 years.
-
Global fiber preform production is expected to reach 18,902 tonnes in 2020
Time of Update: 2023-01-03
With the expansion of production by major Chinese producers, China has become the world's largest producer of fiber optic preforms, with a production capacity of 16,426 tons/year in 2019 (basically meeting the domestic market demand), accounting for 61.
-
In 2020, investment in new wind power projects in Europe reached 42.8 billion euros, an increase of 75% year-on-year
Time of Update: 2023-01-03
Last year, 24 new wind PPAs covered more than 2 GW of capacity.
Last year, 24 new wind PPAs covered more than 2 GW of capacity.
Last year, 24 new wind PPAs covered more than 2 GW of capacity.
-
By 2027, the global 5G infrastructure market size may exceed $47.7 billion
Time of Update: 2023-01-02
The increase in cross-industry M2M connectivity is also expected to drive the growth of the 5G infrastructure market during the forecast period.
The increase in cross-industry M2M connectivity is also expected to drive the growth of the 5G infrastructure market during the forecast period.
-
BI rare skin disease drug San Lizo China approved; China Pharmaceutical will be responsible for the import and distribution of Paxlovid in Chinese mainland
Time of Update: 2022-12-30
Pharmacis SelectionPharmacis SelectionBoehringer Ingelheim rare dermatology drug IL-36R monoclonal antibody San Ligzo China approvedBoehringer Ingelheim rare dermatology drug IL-36R monoclonal antibody San Ligzo China approvedBoehringer Ingelheim today announced that its application for the marketing of its innovative drug for rare skin diseases, San Lizo (pesolimab injection), has been approved by the State Food and Drug Administration for the treatment of generalized pustular psoriasis (GPP) in adults.
-
Shanghai aluminum high volatility short-term may have a pullback
Time of Update: 2022-12-15
Shanghai aluminumIn terms of industry, Brazilian aluminum production hit its lowest level since the end of the last century in 2018, and in the face of pressure on energy costs, the Brazilian Aluminum Association (Abal) said in its 2019 aluminum industry supply and demand and outlook report released on Monday that the outlook for aluminum production in 2019 depends on the full resumption of production at the Alunorte alumina plant in Pará.
-
Issue 9/2020 - Qingdao Energy prepares solid electrolyte from nylon 6
Time of Update: 2022-11-14
This highly Lewis acidic cation "attacks" the acyl group in the amide bond and coordinates to dissolve nylon 6.
This highly Lewis acidic cation "attacks" the acyl group in the amide bond and coordinates to dissolve nylon 6.
-
Issue 14/2020 - Global Chemicals Quick Facts
Time of Update: 2022-11-11
BP has agreed to sell its global petrochemical business to INEOS for $5 billion, with INEOS paying a $400 million deposit and a further $3.
-
Comparison of various specifications and models of integrated distillators
Time of Update: 2022-10-13
Chuanyi instrument integrated distillation instrument product specifications: integrated distillation instrument is mainly for external cooling water device and built-in compressor device two categories.
-
Studies related to the treatment of glibenclamide in the treatment of ischemic cerebrovascular disease
Time of Update: 2022-09-30
At present, the clinical treatment method is more effective and conservative, but a large number of clinical data show that the probability of mid-cerebral artery infarction in patients with ischemic stroke after conservative treatment is as high as (41-79%), and mass cerebral swelling due to the damage of the blood-brain barrier is currently considered the most important cause of death, followed by secondary intracranial hypertension and hernia.
-
Professor Wu Lin: From 5 real cases, the efficacy and safety of sivotinib in clinical practice are seen
Time of Update: 2022-09-07
(Click to see full case) Case 4: A 60-year-old female patient with multiple metastases of right lung non-small cell carcinoma with multiple metastases (cT3NxM1, stage IV), after genetic testing found that the MET 14 exon-jump mutation, was treated with cevotinib first-line therapy, the onset of action was rapid, reaching PR at 1 month, and the PFS was maintained for 8 months.
-
Russia's polystyrene imports increase in January-November
Time of Update: 2022-08-21
. In January-November 2019, Russian GPPS imports increased by 25% year-on-year to 25,600 tons, while HIPS imports fell for the third consecutive month .
. In January-November 2019, Russian GPPS imports increased by 25% year-on-year to 25,600 tons, while HIPS imports fell for the third consecutive month .
-
Vietnam expected to use African swine fever vaccine on a large scale by the end of 2022
Time of Update: 2022-08-16
NDO - Nguyen Van Long, Acting Director of the Veterinary Department of the Ministry of Agriculture and Rural Development of Vietnam, said that Vietnam 's Central Animal Medicine Joint Stock Company (Navetco) has selected more than 50 farms in 10 provinces and cities to carry out 600,000 doses of African swine fever vaccination .
-
Prostate cancer should be checked at age
Time of Update: 2022-05-02
Considering the impact of prostate cancer screening on people's quality of life and length of life, and the condition of most prostate cancer patients The development is relatively slow, and the "Guidelines" recommend that for high-risk groups under the age of 75 and with a life expectancy of more than 10 years, the first screening test using serum prostate-specific antigen (PSA) test is performed every two years .
-
Clin Cancer Res: Fudan Tumor's new therapy for advanced immunomodulatory triple-negative breast cancer (TNBC) with an effective rate of 95.8
Time of Update: 2022-04-22
In conclusion, the study shows that the triple regimen of famitinib + camrelizumab + nab-paclitaxel has significant efficacy and good safety in the treatment of advanced immunomodulatory TNBC .
